Kevin J Yarema Selected Research

Kevin J Yarema Research Topics

Disease

17	Neoplasms (Cancer) 01/2020 - 01/2005
5	Breast Neoplasms (Breast Cancer) 01/2018 - 04/2008
5	Pancreatic Neoplasms (Pancreatic Cancer) 10/2016 - 07/2012
2	Inflammation (Inflammations) 01/2016 - 09/2013
2	Neoplasm Metastasis (Metastasis) 07/2012 - 04/2012
1	Arterial calcification of infancy 01/2021
1	Carcinogenesis 01/2020
1	Colonic Neoplasms (Colon Cancer) 01/2017
1	Osteoarthritis 01/2016
1	Carcinoma (Carcinomatosis) 01/2013
1	Lymphoma (Lymphomas) 08/2011
1	Parkinson Disease (Parkinson's Disease) 11/2010
1	Communicable Diseases (Infectious Diseases) 05/2010
1	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 05/2010
1	Leukemia 11/2009
1	Human Influenza (Influenza) 03/2007
1	Nervous System Diseases (Neurological Disorders) 08/2006
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2006
1	Nonaka type Distal myopathy 05/2004

Drug/Important Bio-Agent (IBA)

9	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2020 - 05/2004
7	SugarsIBA 01/2017 - 08/2006
7	Pharmaceutical PreparationsIBA 10/2016 - 12/2008
5	Polysaccharides (Glycans)IBA 12/2015 - 11/2009
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 07/2012
3	N-acetylmannosamineIBA 01/2018 - 12/2008
3	Sialic AcidsIBA 01/2017 - 08/2006
3	CarbohydratesIBA 01/2016 - 12/2006
3	OligosaccharidesIBA 01/2015 - 03/2007
3	Volatile Fatty AcidsIBA 05/2010 - 12/2006
2	EnzymesIBA 01/2021 - 05/2004
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 01/2015
2	MonosaccharidesIBA 01/2017 - 05/2010
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 10/2016 - 03/2015
2	Gefitinib (Iressa)FDA Link 10/2016 - 03/2015
2	Tyrosine Kinase InhibitorsIBA 10/2016 - 03/2015
2	AcetylglucosamineIBA 01/2016 - 05/2004
2	LectinsIBA 12/2015 - 01/2015
2	Glycoproteins (Glycoprotein)IBA 01/2015 - 07/2012
2	Sulfhydryl Compounds (Thiols)IBA 08/2011 - 01/2006
2	Butyrates (Butyrate)IBA 12/2008 - 12/2006
1	PyrophosphatasesIBA 01/2021
1	Oncogene Proteins (Oncogene Protein)IBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2018
1	Alkynes (Acetylenes)IBA 01/2018
1	EpitopesIBA 01/2017
1	EsterasesIBA 01/2017
1	ErbB Receptors (EGF Receptor)IBA 10/2016
1	Polylactic Acid-Polyglycolic Acid CopolymerIBA 01/2016
1	Biological ProductsIBA 11/2015
1	SialoglycoproteinsIBA 01/2015
1	Peptides (Polypeptides)IBA 01/2015
1	Transcription Factors (Transcription Factor)IBA 09/2013
1	FetuinsIBA 04/2013
1	AndrogensIBA 01/2013
1	KetonesIBA 04/2012
1	SelectinsIBA 04/2012
1	Biocompatible Materials (Biomaterials)IBA 08/2011
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 11/2010
1	ZM 241385 (ZM241385)IBA 11/2010
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 05/2010
1	PolymersIBA 05/2010
1	sebacic acidIBA 05/2010
1	GlycosyltransferasesIBA 11/2009
1	Mannose (D-Mannose)IBA 12/2008
1	HexosaminesIBA 12/2008
1	Antineoplastic Agents (Antineoplastics)IBA 04/2008
1	Histones (Histone)IBA 12/2006
1	ProdrugsIBA 12/2006
1	maleimideIBA 01/2006
1	isothiocyanic acidIBA 01/2006
1	1,3,4,6- tetra- O- acetyl- 2- acetylthioacetamido- 2- deoxymannopyranoseIBA 01/2006
1	fluorescein isothiocyante avidinIBA 01/2006
1	Biotin (Vitamin H)FDA Link 01/2006
1	Fluorescein (Funduscein)FDA LinkGeneric 01/2006
1	Indicators and Reagents (Reagents)IBA 01/2006
1	Dendrimers (Dendrons)IBA 01/2005
1	Racemases and Epimerases (Epimerases and Racemases)IBA 05/2004
1	N-acylmannosamine kinaseIBA 05/2004
1	Uridine Diphosphate (UDP)IBA 05/2004

Therapy/Procedure

3	Therapeutics 01/2017 - 08/2006
2	Immunotherapy 10/2019 - 01/2017
1	Precision Medicine 01/2017
1	Ligation 01/2015